GH

Gundreddy Harinadh Reddy

Active Director Director DIN 10314591
DIN 10314591 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gundreddy Harinadh Reddy

Data last updated:

Gundreddy Harinadh Reddy is a Director at Star Shield Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10314591
Primary Designation Director
Industry Pharma
First Appointment 12 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Sep 20232023Active

Board colleagues of Gundreddy Harinadh Reddy

NameDINCompanyDesignation
Umesh Kumar Gundla10314592Star Shield Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Star Shield Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gundreddy Harinadh Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gundreddy Harinadh Reddy

Gundreddy Harinadh Reddy currently holds 1 directorship: Star Shield Pharmaceuticals Private Limited (Director, since 12 Sep 2023).

Gundreddy Harinadh Reddy was first appointed on 12 Sep 2023 as Director at Star Shield Pharmaceuticals Private Limited.

The current boards of Gundreddy Harinadh Reddy's companies include Umesh Kumar Gundla (Star Shield Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available